The First Dual ChE/FAAH Inhibitors: New Perspectives for Alzheimer's Disease?-Reference-Cited by-同舟云学术

The First Dual ChE/FAAH Inhibitors: New Perspectives for Alzheimer's Disease?

Published:2012-01-26 Issue:3 Volume:3 Page:182-186
ISSN:1948-5875
Container-title:ACS Medicinal Chemistry Letters
language:en
Short-container-title:ACS Med. Chem. Lett.

Author:

Rampa Angela¹,Bartolini Manuela¹,Bisi Alessandra¹,Belluti Federica¹,Gobbi Silvia¹,Andrisano Vincenza¹,Ligresti Alessia²,Di Marzo Vincenzo²

Affiliation:

1. Department of Pharmaceutical Sciences, Alma Mater Studiorum, University of Bologna, Via Belmeloro 6, 40126 Bologna, Italy

2. Endocannabinoid Research Group, Institute of Biomolecular Chemistry, National Research Council, Via Campi Flegrei 34 Comprensorio Olivetti, 80078 Pozzuoli, NA, Italy

Publisher

American Chemical Society (ACS)

Subject

Organic Chemistry,Drug Discovery,Biochemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/ml200313p

Reference30 articles.

1. The Amyloid Hypothesis of Alzheimer's Disease: Progress and Problems on the Road to Therapeutics

2. Tau protein isoforms, phosphorylation and role in neurodegenerative disorders11These authors contributed equally to this work.

3. Evidence of Oxidative Stress in Alzheimer's Disease Brain and Antioxidant Therapy

4. Cholinergic function and Alzheimer's disease

5. Neurobiology of butyrylcholinesterase

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cannabis sativa;Cannabis sativa Cultivation, Production, and Applications in Pharmaceuticals and Cosmetics;2023-01-27

2. Approved Cholinesterase Inhibitor-Based Derivatives: Synthesis and Their Biological Evaluation;Natural Product-based Synthetic Drug Molecules in Alzheimer's Disease;2023

3. Progress and Development of Carbazole Scaffold Based as Potential Anti- Alzheimer Agents Using MTDL Approach;Letters in Drug Design & Discovery;2022-12

4. Recent advance on carbamate-based cholinesterase inhibitors as potential multifunctional agents against Alzheimer's disease;European Journal of Medicinal Chemistry;2022-10

5. Polypharmacological Approaches for CNS Diseases: Focus on Endocannabinoid Degradation Inhibition;Cells;2022-01-29